FDA approves pill that cuts COVID risk nearly 70% (opens in new tab)

The US has its first and only oral COVID-19 post-exposure prophylaxis (PEP) on its way, after a Phase III trial of the drug ensitrelvir met goals required for approval by the US Food and Drug Administration (FDA).Continue ReadingCategory: Infectious Diseases, Illnesses and conditions, Body and MindTags: FDA, Coronavirus (COVID-19), Drug development, Virus, Transmission